Bcl-xL antagonist 2, CAS [[1235032-75-3]]

Produktübersicht

• Artikelname: Bcl-xL antagonist 2, CAS [[1235032-75-3]]
• Artikelnummer: MCE-HY-12908
• Hersteller Artikelnummer: HY-12908
• Alternativnummer: MCE-HY-12908-10MMX1ML,MCE-HY-12908-5MG,MCE-HY-12908-100MG,MCE-HY-12908-25MG,MCE-HY-12908-10MG,MCE-HY-12908-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Bcl-xL antagonist 2 is a potent, selective, and orally active antagonist of BCL-XL with an IC50 and Ki of 0.091 µM and 65 nM, respectively. Bcl-xL antagonist 2 promotes the apoptosis of cancer cells. Bcl-xL antagonist 2 has the potential for the research of the chronic lymphocytic leukemia (CLL) and non-Hodgkins lymphoma (NHL)[1][2].

Produkteigenschaften

• Molekulargewicht: 436.51
• Reinheit: 98.86
• CAS Nummer: [1235032-75-3]
• Formel: C21H16N4O3S2
• Target-Kategorie: Apoptosis,Bcl-2 Family

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound